• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[乳腺癌中的免疫形态学标志物]

[Immunomorphologic markers in breast cancer].

作者信息

Volchenko N N, Litvinova L V, Pugachev K K, Shimbireva I B, Kalashnikov V V, Frank G A

出版信息

Arkh Patol. 1996 Jan-Feb;58(1):6-10.

PMID:8929144
Abstract

Mammary carcinoma (MC) of various histological structure are studied immunomorphologically. Positive reaction with proliferative cells nuclear antigen (PCNA) oncoprotein cerbB-2, carcinoembryonic antigen (CEA), trophoblastic beta 1 globulin (TBG) and tissue protein ferritin (Fe) was observed in one third, and with cyprein in half of MC cases. Clear-cut dependence of immunomorphological parameters upon histologic structure and degree of malignancy was not established. An increase of PCNA content with the tumor size increase was observed. There is a tendency to more frequent observation of CEA, Fe, TBG in the presence of the lymph nodes metastases. Most unfavourable for the prognosis are combinations of positive reactions of CEA with TBG, CEA with OCNA, CEA with cerbB-2 as well as PCNA, cerbB-2, CEA.

摘要

对各种组织学结构的乳腺癌(MC)进行了免疫形态学研究。在三分之一的MC病例中观察到与增殖细胞核抗原(PCNA)、癌蛋白cerbB - 2、癌胚抗原(CEA)、滋养层β1球蛋白(TBG)和组织蛋白铁蛋白(Fe)呈阳性反应,在一半的MC病例中观察到与鱼精蛋白呈阳性反应。未确定免疫形态学参数与组织结构和恶性程度之间存在明确的相关性。观察到PCNA含量随肿瘤大小增加而增加。在存在淋巴结转移的情况下,CEA、Fe、TBG更常被观察到。对预后最不利的是CEA与TBG、CEA与OCNA、CEA与cerbB - 2以及PCNA、cerbB - 2、CEA的阳性反应组合。

相似文献

1
[Immunomorphologic markers in breast cancer].[乳腺癌中的免疫形态学标志物]
Arkh Patol. 1996 Jan-Feb;58(1):6-10.
2
[Immunomorphological characteristics of primary and recurrent breast neoplasms].[原发性和复发性乳腺肿瘤的免疫形态学特征]
Arkh Patol. 1998 Jul-Aug;60(4):4-7.
3
mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.乳腺癌淋巴结转移的mRNA标志物:248例患者中乳腺珠蛋白与癌胚抗原的比较
J Pathol. 2001 Sep;195(2):186-90. doi: 10.1002/path.943.
4
Breast carcinoma detection with a combination of radiolabeled monoclonal antibodies. Promising results from immunohistochemistry studies.用放射性标记单克隆抗体组合检测乳腺癌。免疫组织化学研究取得了有前景的结果。
Cancer. 1996 Dec 1;78(11):2334-9.
5
[Human breast cancer markers].
Eksp Onkol. 1985;7(4):3-8.
6
Prospective evaluation of tumor markers (c-erbB-2 oncoprotein, CEA and CA 15.3) in patients with locoregional breast cancer.局部区域性乳腺癌患者肿瘤标志物(c-erbB-2癌蛋白、癌胚抗原和CA 15.3)的前瞻性评估
Anticancer Res. 2003 Mar-Apr;23(2A):1043-50.
7
[The role of epithelial antigens in diagnosis and staging of breast cancer].
Arkh Patol. 2002 Nov-Dec;64(6):13-5.
8
Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.MAGE - A4、NY - ESO - 1和HER - 2抗原在复发性浸润性导管癌女性中的表达及可能的预后作用:回顾性免疫组化研究
Croat Med J. 2006 Feb;47(1):32-41.
9
Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.组织多肽抗原(TPA)和癌胚抗原(CEA)在乳腺癌中的免疫细胞化学定位差异
Cancer Detect Prev. 1983;6(1-2):193-8.
10
Immunohistochemical expression of p53 and c-erbB2 proteins in breast cancer in Egypt.p53和c-erbB2蛋白在埃及乳腺癌中的免疫组化表达
Anticancer Res. 2000 May-Jun;20(3B):2145-50.